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Fibroblast growth factors (FGFs) and their receptors are expressed in a variety of mammalian tis-
sues, playing a role in development and cell proliferation. While analyzing human sperm motility,
we found that sperm treated with endo-b-galactosidase (EBG), which speciﬁcally hydrolyzes poly-
N-acetyllactosamine type glycans (polyLacs), enhanced motility. Mass spectrometry analysis
revealed that sperm-associated polyLacs are heavily fucosylated, consistent with Lewis Y antigen.
Immunohistochemistry of epididymis using an anti-Lewis Y antibody before and after EBG treat-
ment suggested that polyLacs carrying the Lewis Y epitope are synthesized in epididymal epithelia
and secreted to seminal ﬂuid. EBG-treated sperm elevated cAMP levels and calcium inﬂux, indicat-
ing activation of ﬁbroblast growth factor signaling. Seminal ﬂuid polyLacs bound to FGFs in vitro,
and impaired FGF-mediated signaling in HEK293T cells.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Poly-N-acetyllactosamine type glycans (polyLacs) are large
carbohydrates composed of galactose and N-acetylglucosamine re-
peats. PolyLacs were speciﬁcally detected due to their susceptibil-
ity to endo-b-galactosidase (EBG) [1–6]. They often carry blood
group or onco-developmental antigens [3,7–9], which are detected
by speciﬁc monoclonal antibodies directed to these carbohydrate
antigens. PolyLacs and their modiﬁed forms are recognized as anti-
gens, i.e., sialyl Lewis X and Y. These antigenic glycans reportedly
function in cell–cell interaction during embryogenesis, tumorigen-
esis and cancer metastasis [10–12].
Because of their large size, polyLacs protect core glycoproteins
from proteolysis [13]. Two lysosomal membrane proteins, LAMP1
and LAMP2, are heavily glycosylated with polyLacs [14]. Mice deﬁ-
cient in Lamp2 accumulate autophagic vacuoles in many tissuesand die prematurely of cardiomyopathy [15]. PolyLacs are likely
essential for survival of mammalian cells in vitro, since no
polyLac-deﬁcient cell line has been generated. Polylacs are
synthesized by sequential activity of B4GALT1 plus either
B3GNT2 [16–19], B3GNT4 [18], B3GNT7 [20,21], and B3GNT8
[16]. B3gnt2 knockout mice exhibit shorter polylac chains than
do wild-type mice, and their T-lymphocytes exhibit increased cal-
cium ﬂux and cell proliferation, suggestive of hyperactivation [16].
There are as yet no reports of mutant mice completely lacking
polyLacs.
Previous studies, including our own, suggested that mature
human sperm cells are densely covered by carbohydrates [22,23].
While we attempted to remove glycans from living human sper-
matozoa using glycosidases, we found human sperm cells treated
with endo-b-galactosidase (EBG) moved more rapidly than
untreated sperm. We investigated the mechanism underlying
EBG-triggered sperm motility and found that seminal ﬂuid poly-
Lacs down regulate sperm motility by impairing ﬁbroblast growth
factor-dependent signaling.
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2.1. Reagents
EBG from Escherichia freundii was obtained from Seikagaku Co.
Ltd. (Tokyo Japan) and also puriﬁed from culture medium of E.
freundii, as described [24]. Bovine corneal keratan sulfate was pre-
pared as described previously [4,25]. Monoclonal anti-Lewis Y
antibody (clone AH6, mouse IgM) [26] was provided by Dr. S.
Hakomori, University of Washington, Seattle, WA. Recombinant
human FGF1 (acidic-FGF) and FGF2 (basic-FGF) were obtained
from Invitrogen/Life Technologies.
2.2. Human sperm and seminal ﬂuid samples
Sperm and seminal ﬂuid samples were obtained for future
research use from 20 study volunteers, who provided verbal in-
formed consent to participate in this study. Written consent was
not obtained, as semen sample collection involves minimum
health risk to human subject. Samples were given number codes
to protect donor identity, and records were kept in a secure com-
puter not accessible under any condition including by the internet.
The ethics committee of the Hamamatsu Red Cross Hospital and
that of Hamamatsu University School of Medicine approved the
consent procedure. Donor fertility was not tested, nor did we
undertake normal semen analysis. Sperm was mixed with sperm
freezing solution from Irvine Scientiﬁc (Santa Ana, CA) and frozen
until analyzed.
2.3. Sperm motility analysis
Sperm motility was analyzed using a SQA-V, sperm quality ana-
lyzer-V [27] (Medical Electronic Systems). Cryopreserved human
sperm from healthy volunteers were washed with sperm washing
medium (Irvine Biologicals) and suspended in the same solution.
EBG was dissolved in water at 1 mUnit/ml. To 100 ll of human
sperm solution (2  106 cells), 5 ll EBG was added at ﬁnal concen-
tration 50 lUnits/ml, and incubated at room temperature for
15 min. A sperm aliquot was placed in a 500 ll SQA-V Measure-
ment Capillary. Statistical analysis was performed using a paired
two-tailed Student’s t-test using the Prism program (GraphPad
Software).
2.4. Measurement of calcium inﬂux and cAMP
Calcium inﬂux into sperm cells was measured using a Fluo-4
NW calcium assay kit (Molecular Probes). Sperm cells treated or
untreated with EBG were assayed in triplicate in 96-well plates.
Fluorescence was measured using a Beckman DTX810 plate reader,
using excitation and emission wavelengths of 495 and 519 nm,
respectively. Cyclic AMP was measured using a competition-based
immunoassay kit for cyclic AMP and GMP XP (Cell Signaling).
2.5. Preparation of sperm-associated glycans and mass spectrometry
analysis
Upon thawing, sperm cells were collected by centrifugation at
400g for 5 min, washed twice with phosphate buffered saline,
and digested with 20 ll Proteinase K (14–22 mg/ml, Roche) at
45 C for 20 h. After removing insoluble materials by centrifuga-
tion, supernatants were treated with 0.5 M NaOH containing 1 M
NaBH4 at 37 C for 20 h. Samples were passed through Sephadex
G-25 equilibrated with water, and materials eluting in the void
volume were pooled and applied to a Sephadex G-50 super ﬁne
column equilibrated with 0.2 M NaCl. Neutral sugars weremonitored by the anthrone color reaction [28], and glycopeptides
carrying large glycans or polyLacs were collected for mass spec-
trometry analysis. The sample was permethylated for MALDI-MS
and MS/MS analyses using conditions as described for recovering
both non-sulfated and sulfated glycans [29].
2.6. Preparation of seminal ﬂuid polyLacs
Human seminal ﬂuid was prepared from a pool of samples. Se-
men was mixed with three volumes of chloroform/methanol (2:1,
v/v) to extract lipids. After centrifugation, the pellet was suspended
with 0.1 M Tris–HCl buffer, pH 8.0, containing 1 mM EDTA, and di-
gested by protease K (20 lg/ml) at 45 C for 20 h. After centrifuga-
tion at 12000g for 30 min, water soluble materials were passed
through Sephadex G-25 equilibrated with water, and materials
eluting in the void volume were applied to a Sephadex G-50 super
ﬁne column as described above. PolyLacs were collected and de-
salted using a Sephadex G-25 column and lyophilized.
2.7. Immunohistochemistry
Parafﬁn-embedded sections of human testis, epididymis, and
ductus deferens tissues were obtained from Folio Biosciences
(Columbus, OH). After deparafﬁnization, hydration and peroxide-
treatment, one of each paired slides was subjected to EBG
treatment at 37 C for 30 min. Tissue specimens were stained by
anti-Lewis Y (clone AH6) antibody [26], followed by biotinylated
goat anti-mouse IgM antibody (Vector) and peroxidase-conjugated
streptavidin. The peroxidase color reaction was performed using
DAB substrate on parafﬁn-embedded tissue sections or AEC single
solution (Invitrogen) on sperm smears, and all tissues were coun-
terstained using hematoxylin. Unwashed and PBS-washed human
sperm cells were smeared on glass slides, air-dried and ﬁxed with
4% paraformaldehyde in PBS. Tissues were then treated with or
without EBG and immunostained as described above for tissue
sections.
2.8. FGF plate binding assay
Human recombinant FGF1 or FGF2 (0.5 lg) was diluted in
100 ll water and added to wells of 96-well polyvinylchloride ﬂat
bottom plates (Coster), which were then incubated 20 h at 4 C.
After washing wells with PBST (0.2 M Na–phosphate buffer, pH
7.4, containing 0.2% Tween 20), wells were blocked with Super-
block 20 (Pierce). PBST (50 ll) with or without heparin (200 lg/
ml) was added to each well and incubated for 15 min at room tem-
perature. Seminal ﬂuid polyLacs (200 lg/ml in PBST, 50 ll) was
then added to each well and incubated for 15 min. After washing
with PBST, diluted (1:3000) anti-LeY antibody (AH6) [26] was
added to wells and reacted at room temperature for 60 min. After
washing with PBST, diluted (1:2000) peroxidase-conjugated anti-
mouse IgM antibody was added and reacted at room temperature
for 30 min. After washing with PBST, wells were reacted with TBM
substrate solution (eBioscience) at room temperature for 30 min
for peroxidase-based color reaction. The color reaction was
stopped by addition of 2 N-sulfuric acid, and absorbance at
450 nm was measured in a plate reader.
2.9. Glycan arrays
Glycan microarrays were printed as described [30]. For the
analysis, v5.1 (www.functionalglycomics.org/static/consortium/re-
sources/resourcecoreh8.shtml) was used. Recombinant FGF2 was
diluted to 200 lg/ml in TBSCM (20 mM Tris, 150 mM NaCl, 2 mM
CaCl2, 2 mM MgCl2, pH 7.4) containing 1% bovine serum albumin
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aliquot was applied to a microarray slide and incubated for
60 min under a coverslip in a humidiﬁed chamber at room temper-
ature. Coverslips were then gently removed in a solution of TBSCM/
0.05% Tween-20 and subjected to the TBS standard wash proce-
dure. To detect protein binding, the slide was similarly incubated
with mouse monoclonal anti-FGF2 antibody (clone bFM2, Milli-
pore) and washed as described. The slide was then incubated in
the dark with anti-mouse IgG antibody labeled with Alexa 488
(Qiagen) at 5 lg/ml, washed as described above, and then washed
with deionized water to remove salts. The slide was then spun in a
slide centrifuge for approximately 15 s to dry and immediately
scanned in a PerkinElmer ProScanArray Scanner using an excita-
tion wavelength of 488 nm and ImaGene software (BioDiscovery,
Inc.) to quantify ﬂuorescence. Data are reported as the average
RFU of four of six replicates (after removal of highest and lowest
values) for each glycan represented on the array.
2.10. FGF binding to HEK293T cells
HEK293T cells were cultured to 75% conﬂuency. To assay FGF
binding to its receptor, medium was completely replaced with
fresh medium containing 10% fetal calf serum and 1 mM Na3VO4
for 30 min. PolyLacs puriﬁed as described above were added to
the monolayer at 1 mg/ml and incubated for 10 min. Recombinant
b-FGF (Sigma) was then added to a ﬁnal concentration of 25 ng/ml
and incubated for 5 min. Cells were then washed three times with
TBS. Cell lysates were prepared with lysis buffer provided in the b-
FGF ELISA kit (Ray Biotech), followed by centrifugation. Each lysate
containing 100 mg protein was subjected to an ELISA inhibition as-
say to determine the amount of FGF bound to cells in the presence
or absence of polyLacs.Fig. 1. Effect of EBG treatment on human sperm. (A) Effect of EBG on sperm motility.
volunteer were treated with (plus) or without (minus) EBG, 50 lUnits/ml, at room temp
test. (C) Effect of EBG on calcium levels measured by ﬂuorescence in human spermatozo
points are shown. (D) Levels of cAMP in human spermatozoa incubated with or withou
Luminescence values are values from EBG-treated cells minus values from buffer-treate2.11. Immunoprecipitation and immunoblotting
HEK293T cells were cultured in medium supplemented with
10% fetal calf serum. Na3VO4 was added to a ﬁnal concentration
of 1 mM and incubated for 30 min. FGF was added to a ﬁnal con-
centration of 25 ng/ml in the presence or absence of polyLacs
(1 mg/ml) and incubated for 5 min. Cell were collected using a
rubber policeman, washed with cold TBS containing 1 mM Na3-
VO4, and lysed with 1% NP-40 in TBS. Each lysate was pre-
cleared with 20 ll protein A/G agarose beads at 4 C for 20 h.
Protein A/G beads (20 ll) were then coated with anti-FGFR2
antibody (2 lg, rabbit polyclonal, GenTex) in 500 ll TBST at
4 C for 20 h. Pre-cleared lysates were reacted with antibody-
coated beads at 4 C for 20 h. Beads were washed three times
with TBST and bead-bound materials were eluted by boiling in
SDS buffer for 3 min. Proteins were resolved on 4–12% gradient
SDS–polyacrylamide gels and transferred to an immobilon-P ﬁl-
ter (Millipore). After blocking with Odyssey blocking buffer (Li-
Cor Biosciences), the ﬁlter was reacted with diluted (1:500)
anti-tyrosine phosphate antibody (4G10, Upstate Biologicals) in
blocking buffer containing 0.1% Tween 20 for 60 min, followed
by incubation of diluted (1:5000) IRDye-conjugated anti-mouse
IgG antibody (Li-Cor Biosciences) for 45 min. After washing with
TBST, the ﬁlter was scanned by the Odyssey imaging system to
detect bands.
2.12. Immunoﬂuorescence microscopy
Semen was smeared on glass slide glasses, air dried and ﬁxed
with 4% paraformaldehyde in PBS at room temperature for
15 min. Sperm cells and seminal ﬂuid on the slide glass were re-
acted with diluted (1:100) anti-FGF2 antibody (rabbit polyclonal,(B) Effect of other enzymes on sperm motility. In (A) and (B), spermatozoa from a
erature for 15 min before analysis. Statistical analysis was via a unpaired 2-tailed t-
a incubated with (black) or without (grey) EBG. The average value of triplicate data
t EBG. Sperm cells were subjected to protein kinase C-based cAMP measurement.
d controls over the test period. Each point represents an average of ten readings.
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IgM) for 1 h. Control slide received no primary antibody. After
washing with PBS, sample was reacted with A568-labeled anti-rab-
bit IgG antibody and A488-labeled anti-mouse IgM antibody. After
washing with PBS, slides were mounted with Vectashield (Vector)
with DAPI.
3. Results
3.1. Effect of EBG on human sperm motility
We analyzed human sperm motility using computer-assisted
sperm motility analyzer. This analysis showed that EBG enhanced
sperm motility, whereas sperm treated with sialidase and with
b-galactosidase showed motility comparable to untreated sperm
(Fig. 1A and B). Treatment with trypsin did not enhance sperm
motility, excluding the possibility that the observed EBG effect is
non-speciﬁc.
Sperm tail motility reportedly requires ATPase and ion channel
activities [31–33]. To begin to analyze these parameters, we mea-
sured calcium levels in sperm and observed that they were signif-
icantly increased in EBG-treated sperm cells (Fig. 1C). Since
calcium ﬂux into sperm is mediated by cyclic nucleotide-depen-
dent gated channels [31], we examined cAMP levels and found that
they were indeed enhanced in EBG-treated sperm cells (Fig. 1D and
Fig. S1). These results suggested that polyLacs attached to the
sperm tail suppressed sperm motility through a cAMP- and cal-
cium channel-dependent mechanism.Fig. 2. Structure and localization of sperm-associated large glycans. (A) Sephadex G-50
tube number 31 and 39 were collected after gel ﬁltration of a mixture of glycopeptides p
(red) EBG digestion. Note that large glycopeptides were digested to fragments eluted a
anthrone color reaction [28]. Arrows show the elution position of blue dextran or void
(lower) glycan fragments afforded by direct permethylation of the same sample, as det
addition to the same series of variably fucosylated [Hex–HexNAc]1–3 glycan fragmen
sialylLacNAc (m/z 825) were detected. In negative ion mode, sulfated and fucosylated [
peaks were labeled and annotated using the symbol set shown.3.2. Isolation and characterization of sperm-associated polyLacs
As a previous study of human sperm glycans did not detect
polyLacs [34], we hypothesized that polyLacs are not an intrinsic
component of human sperm but are derived from seminal ﬂuid
and associated with the tail. To characterize sperm-associated
polyLacs, we isolated sperm cells from semen washed twice with
PBS. Sperm cells were then digested with protease K, and water-
soluble materials were fractionated by gel ﬁltration. This analysis
revealed the existence of large carbohydrates, presumably poly-
Lacs (Fig. 2A-a). Following EBG treatment, a substantial portion
of large carbohydrates was converted to smaller fragments, dem-
onstrating that they are indeed polyLacs (Fig. 2A-b).
MALDI-MS analysis of sperm-associated polyLacs revealed the
presence of sulfated, sialylated, fucosylated Hex–HexNAc units
(Fig. 2B). Notably, the presence of blood group H antigen, LeX
antigen and LeY antigen was evident based on both composition
and additional MS/MS analysis (Table S1). In particular, in-source
prompt fragmentation yielded oxonium ions at m/z 638 and 812,
corresponding to LacNAc with 1 and 2 Fuc, respectively. Further-
more, glycan fragments with compositions such as 3 LacNAc and
4 Fuc with and without additional sulfate were detected. Thus
the internal portion of polyLacs was highly substituted with
fucose, in addition to sialylation and sulfation seen at the
termini.
To determine the origin of sperm-associated polyLacs, we per-
formed immunohistochemistry of human tissue from organs func-
tioning in spermatogenesis using anti-Lewis Y antibody in tissuesgel ﬁltration chromatograms of seminal ﬂuid polyLacs. (a) PolyLacs eluted between
repared from pooled seminal ﬂuid. (b) Seminal ﬂuid polyLacs before (blue) and after
t tube numbers 42–56 and 64–77. Each fraction was monitored for hexose by an
volume. (B) MALDI-TOF mass spectrometry of non-sulfated (upper) and sulfated
ected in positive and negative ion modes as [M+Na]+ and [MH], respectively. In
ts, oxonium ions corresponding to terminal H/LeX (m/z 638), LeY (m/z 812) and
Hex–HexNAc]1–4 fragments with and without sialylation were identiﬁed. All major
Fig. 3. Immunohistochemistry of tissue sections and sperm smears using anti-
Lewis Y antibody. (a) Testis; (b) epididymis; (c) ductus deferens; (d) human semen;
(e) PBS-washed sperm. Tissue sections and semen or sperm smeared slides were
treated with (right) or without (left) EBG and immunostained by anti-Lewis Y
antibody. Note that spermatogenic cells in testis (arrowheads in (a)) are not stained,
whereas epithelial cells of ductuli epididymis (short arrows in (b)) and mucus in
ductuli efferentis (long arrows in (c)) were stained positively with the antibody.
Scale bars: 100 lm (a–c), 50 lm (d and e).
Fig. 4. Binding of seminal ﬂuid polyLacs to FGF. (A) Plastic plates were coated with
recombinant human FGF1 or FGF2 prior to addition of polyLacs. PolyLacs bound to
each well were assessed by anti-LeY antibody (AH6, mouse IgM) followed by
peroxidase-conjugated anti-mouse IgM antibody and analysis using a peroxidase
color reaction. (B) Dose-dependent binding of seminal ﬂuid polyLacs to FGF1, FGF2,
and epidermal growth factor (EGF). (C) Top 10 strongest binders are: 152,
Galb1-4(Fuca1-3)GlcNAcb-Sp8; 296, 4S(3S)Galb1-4GlcNAcb-Sp0; 447, Galb1-
4(Fuca1-3)GlcNAcb1-6GalNAc-Sp14; 416, Fuca1-2Galb1-4(Fuca1-3)GlcNAcb1-
3GalNAca-Sp14; 7, Fuca-Sp9; 478, Neu5Aca2-3Galb1-4GlcNAcb1-2Mana-Sp0; 31,
(3S)Galb1-3GlcNAcb-Sp8; 375, Fuca1-4(Fuca1-2Galb1-3)GlcNAcb1-2Mana1-
3(Fuca1-4(Fuca1-2Galb1-3)GlcNAcb1-2Mana1-3)Manb1-4GlcNAcb1-4GlcNAcb-
Sp19; 175, GlcNAcb1-2Galb1-3GalNAca-Sp8; 58, Fuca1-2Galb1-3GalNAcb1-3Gala-
Sp9; 545, GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-2Mana1-6(GlcNAcb1-
3Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-2Mana1-3)Manb1-4GlcNAcb1-4GlcNAcb-
Sp12. (D) Effect of heparin on polyLac binding to FGFs. PolyLac binding to FGF1 (a)
and FGF2 (b) in the presence or absence of heparin at 100 lg/ml.
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antigen (Fig. 3a), LeY antigen was seen in epithelial cells of tissue
from epididymis, which contains spermatozoa newly released
from testis (Fig. 3b) and from ductus deferens, which contains fully
matured spermatozoa (Fig. 3c). A semen smear, which contains a
mixture of sperm cells and seminal ﬂuid, was positive for LeY anti-
gen (Fig. 3d), but LeY antigen was lost from these tissue sections
after EBG treatment (Fig. 3c and d, right panels). A twice-washed
spermatozoa smear treated with EBG showed loss of LeY positivity
(Fig. 3e). These results strongly suggest that LeY antigenic polyLacs
attached to mature sperm cells were secreted from epithelial cells
of the epididymis and/or ductus deferens into seminal ﬂuid.3.3. Binding of polyLacs to FGF
Increased cAMP levels seen in EBG-treated sperm (Fig. 1D) sug-
gested a role for FGF signaling in the process, since FGF activates
the FGFR to increase cAMP levels through the PLCc/Ca2+/PKC path-
way [35]. We tested polyLac binding to FGFs by a plate assay, using
plates coated either by recombinant FGF1 or FGF2. Seminal ﬂuid
polyLac bound to both FGF1 and FGF2 (Fig. 4A and B), whereas
the same polyLacs did not bind to epidermal growth factor
(Fig. 4B). Glycan array analysis conﬁrmed FGF2 binding to sulfated
glycans and fucosylated and non-fucosylated polyLac structures
(Fig. 4C). Immunoﬂuorescence microscopy of human semen
showed co-localization of FGF2 and LeY (Fig. S2).
It is known that FGFs interact with heparin and/or heparan sul-
fate, which is essential for FGFR binding and subsequent signaling
[36,37]. We asked if polyLacs bind to FGF at the heparin-binding
site, by testing the effect of heparin on polyLac binding to FGF by
plate assay (Fig. 4D). Results clearly showed that heparin has no
inhibitory effect of polyLac binding to FGF1 and FGF2.
3.4. Effect of polyLacs on FGF signaling
The results described above suggest that FGF binds to polyLacs,
potentially hindering FGF binding to cell surface receptors and
Fig. 5. Effect of polyLacs on FGF signaling in HEK293T cells. (A) Binding of FGF to HEK293T cells in the presence or absence of polyLacs. FGF was measured by FGF-ELISA
inhibition assay. (B) Time course of FGFR2 tyrosine phosphorylation in response to addition of FGF to cells. (C) Effect of seminal ﬂuid polyLacs on tyrosine phosphorylation of
FGFR2. In (B) and (C), cells were treated with FGF in the presence or absence of polyLacs, and lysates were immunoprecipitated with anti-FGFR2 antibody and immunoblotted
for phospho-tyrosine (upper panel). The ﬁlter was then stripped and immunoblotted for FGFR2 (lower panel). (D) Effect of FGF on motility of EBG-treated human sperm.
Sperm samples from three individuals were tested. Statistical analysis was performed using a paired, one-tailed t-test. (E) Proposed mechanism for polyLac-dependent
regulation of sperm motility. Human sperm tails express the receptor tyrosine kinase FGFR2 and CATSPER1, a cAMP-dependent calcium channel. FGF binds to polyLacs near
the sperm tail surface, which hinders FGF binding to the receptor and result in attenuation of sperm motility (left). Once polyLacs are removed by EBG digestion, FGF binds
FGFR2 and stimulates tyrosine phosphorylation, resulting in PLCc and PKC signaling [39], calcium ﬂux through cyclic nucleotide-gated channels, and enhanced sperm
motility (right).
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many cell types, we asked whether this effect occurs in other cell
types. To do so, we employed HEK293T cells, since a publicly avail-
able gene expression database indicates that this line expresses
high levels of FGFR2 mRNA. Binding of FGF to HEK293T cells was
signiﬁcantly higher in the absence of seminal ﬂuid polyLacs com-
pared to binding in the presence of polyLacs (Fig. 5A), suggesting
that these glycans block FGF binding to the receptor. Moreover, fol-
lowing addition of FGF to HEK293T cells, FGFR2 became tyrosine-
phosphorylated, with activity peaking in 5 min (Fig. 5B), whereas
FGFR2 tyrosine phosphorylation at that time point was inhibited
by seminal ﬂuid polyLacs (Fig. 5C).
Above described results suggest a possibility that removal of
polyLacs and supplementing FGF increases FGF signaling. We
tested this hypothesis by comparing human spermmotility follow-
ing treatment with EBG, FGF or both. EBG or FGF treatment in-
creased motility relative to untreated control sperm, but the
highest motility was observed in sperm treated with both (Fig. 5D).
4. Discussion
Here, we show that human sperm tail is heavily covered by
fucosylated, sialylated and sulfated polyLacs. EBG treatment re-
moved these glycans from the sperm tail, leading to increased
motility, calcium inﬂux and increased cAMP levels (Fig. 1). There-
fore we propose that mechanisms underlying sperm motility re-
quire cAMP signaling, which potentially targets sperm-speciﬁc
calcium transporters, such as CatSpers [38,39] (Fig. 5E).
Several studies have reported structures of glycans isolated
from seminal ﬂuid glycoproteins, including a1-acid glycoprotein
[40], clusterin, galectin-3-binding glycoprotein, prostatic acid
phosphatase, protein C inhibitor [41], and glycodelin [42,43]. How-
ever, polyLacs were not found in these glycoproteins. It is likely
that the polyLacs characterized here are carried by a speciﬁc carrier
protein, which have yet to identify. Identiﬁcation of a seminal ﬂuidglycoprotein carrying polyLacs may provide important insight into
regulation of sperm motility.
We showed in this study that FGFs bind to complex glycans of
which structures are shared with seminal ﬂuid polyLacs (Fig. 4C).
It is known that heparin and heparan sulfate bind to both FGF
and FGFR, which promotes the ligand-receptor binding and tyro-
sine phosphorylation of FGFR [35,37]. However, our binding assays,
including the glycan array, did not demonstrate polyLac binding to
FGFR2R2 (data not shown). By contrast, polyLacs bound to FGFs
(Fig. 4). Interestingly, heparin did not inhibit polyLac binding to
FGFs (Fig. 4D), suggesting that polyLacs binds to FGF at the site
distinct from heparin binding site. Furthermore, it appears that
binding of polyLacs to FGFs was enhanced in the presence of
heparin. This effect was clearly demonstrated by binding of
sulfated polyLac, keratin sulfate, to FGF2: binding of keratin sulfate
was elevated in the presence of heparin (Fig. S3). These observa-
tions not only exclude a possibility that polyLacs attenuate FGF
signaling by inhibiting heparin binding to FGF, but also suggest a
possibility that heparin-bound FGF changes its conformation to
be favorable for polyLac binding.
We show here that tyrosine phosphorylation of FGFR2 in
HEK293T cells grown under normal tissue culture conditions is
down-regulated by seminal ﬂuid polyLacs (Fig. 5A–C). This ﬁnding
suggests that polyLac-mediated regulation of FGF occurs in a vari-
ety of tissue types. Thus, we conclude that sperm cells employ a
conserved mechanism requiring highly concentrated polyLacs to
regulate motility.
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